Purchase Order 75N93020P00796

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation for $13,121.80 on August 12, 2020, for the supply of fetal bovine serum. Place of performance is Grand Island, New York. The order was due for completion by November 10, 2020. Pricing is firm fixed price with no set-aside designation.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Gemini Bioproducts LLC for $15,006.97 on August 31, 2020, for benchmark fetal bovine serum, heat inactivated, 500 mL with a one-year storage option. Performance occurs in Broderick, California. The order is firm fixed-price with an ultimate completion date of February 27, 2021.</p>

This federal contract award, with an ID of 75N93024P00957, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to the prime contractor Research And Diagnostic Systems, Inc. (R&amp;D Systems). The $14,214 firm fixed-price purchase order is for the provision of proprietary biological and reagent products, including antibodies, ELISA kits, recombinant proteins, and assays, to support biomedical...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Gemini Bioproducts LLC for $102,116.06 on March 24, 2017, for fetal bovine serum under a total small business set-aside. Place of performance is Westlake, Maryland. The order has a firm fixed price structure and an ultimate completion date of March 23, 2018.</p>

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a firm fixed-price purchase order contract to Biowest USA Inc. for the procurement of BIOWEST FETAL BOVINE SERUM USDA ORIGIN. The contract has a ceiling value of $24,717.02 and a period of performance ending on September 16, 2024. The contract does not have a set-aside designation. As NIAID is a research-focused agency within the U.S. Department of Health and Human Services, this contract is likely to...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Biolegend, Inc. for $10,810.00 on August 18, 2020. The order covers biomedical reagents and research materials to be supplied from San Diego, California with a completion date of September 16, 2020. No set-aside applied.</p>

This federal contract award, valued at $12,103.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services. The contract was awarded to Research And Diagnostic Systems, Inc. (R&amp;D Systems), a for-profit manufacturer of laboratory research supplies including proteins, antibodies, and assay kits. The contract is for the delivery of biological supplies and reagent kits, and does not have a set-aside...

<p>This is a $9,151.64 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS), to Atlanta Biologicals Incorporated. The contract is for the purchase of fetal bovine serum (FBS). There is no set-aside designation indicated. The purchase order was awarded on July 22, 2014 with a completion date of July 27, 2014.</p>

The National Cancer Institute awarded a $16,250 firm fixed price Blanket Purchase Agreement (BPA) call to Research and Diagnostic Systems, Inc. (R&amp;D Systems) on May 5, 2021, for fetal bovine serum premium in 500 mL quantities. The contract, which was completed by May 27, 2021, was performed in Minneapolis, Minnesota, where R&amp;D Systems is headquartered. No set-aside designation was used for this procurement, indicating open competition. R&amp;D Systems, a subsidiary of Bio-Techne...

The U.S. National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a $23,380.00 firm fixed price purchase order to Research And Diagnostic Systems, Inc. (R&amp;D Systems), a small business manufacturer of research reagents and instruments. The contract is for the delivery of recombinant proteins, which are likely to support NIAID's biomedical research and investigation efforts, including potential COVID-19-related...